-
Mashup Score: 5COVID-19 Vaccines Should Be Monovalent and Contain the XBB Strain, FDA Committee Recommends - 11 month(s) ago
The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted 2023-2024 COVID-19 vaccines should be updated to a monovalent XBB strain.
Source: ContagionLiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 4
An experimental RSV vaccine developed by Pfizer to protect infants — by vaccinating pregnant people — was shown to be effective in preventing severe lower respiratory tract disease, the FDA said.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Pfizer indicates their RSV vaccine candidate, Abrysvo (RSVpreF), to prevent acute respiratory disease and lower respiratory tract disease caused by respiratory syncytial virus (RSV) in adults 60 years and older by active immunization.
Source: ContagionLiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0FDA Advisory Committee Votes to Unify the Strain Composition of COVID-19 Primary and Booster Vaccines - 1 year(s) ago
The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted to move toward a unified strain composition for COVID-19 primary and booster vaccines.
Source: OncLiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 1FDA Advisory Committee Votes to Unify the Strain Composition of COVID-19 Primary and Booster Vaccines - 1 year(s) ago
The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted to move toward a unified strain composition for COVID-19 primary and booster vaccines.
Source: OncLiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 51FDA advisers recommend updating Covid vaccines - 1 year(s) ago
Advisers to the FDA voted Thursday to back a plan whereby all Covid vaccines would move to the formulation used for the updated boosters, a step toward the goal of creating a single annual Covid shot for most Americans.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
In a surprisingly conflict-free #VRBPAC meeting, the committee voted 21-0 to support FDA's plan to move towards a simplified #Covid vaccination program with a single composition for primary series & boosters. https://t.co/FpLYgGgIXZ
-
-
Mashup Score: 3
Live blog: STAT’s @helenbranswell and @matthewherper are tracking today’s meeting of the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 9
Live blog: STAT’s @helenbranswell and @matthewherper are tracking today’s meeting of the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 31
Live blog: STAT’s @helenbranswell and @matthewherper are tracking today’s meeting of the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Ahead of FDA VRBPAC, a Glimpse of COVID-19 Vaccine Changes - 1 year(s) ago
In this week’s meeting, FDA is expected to ask their advisory committee to consider changes to simplify the vaccination schedule and look at delivering it annually, much like an influenza vaccine.
Source: OncLiveCategories: Infectious Disease, Latest HeadlinesTweet
Last night, the FDA's vaccine advisory committee (#VRBPAC) unanimously recommended the next generation of COVID-19 vaccines should be monovalent and contain the XBB strain. #BreakingNews #ICYMI https://t.co/ejm9vOV9fq